CA2501220A1 - Vaccins contre le virus du nil occidental - Google Patents
Vaccins contre le virus du nil occidental Download PDFInfo
- Publication number
- CA2501220A1 CA2501220A1 CA002501220A CA2501220A CA2501220A1 CA 2501220 A1 CA2501220 A1 CA 2501220A1 CA 002501220 A CA002501220 A CA 002501220A CA 2501220 A CA2501220 A CA 2501220A CA 2501220 A1 CA2501220 A1 CA 2501220A1
- Authority
- CA
- Canada
- Prior art keywords
- west nile
- cell
- nile virus
- lineage
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000710886 West Nile virus Species 0.000 title claims abstract 15
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 claims abstract 12
- 210000005260 human cell Anatomy 0.000 claims abstract 6
- 241000701161 unidentified adenovirus Species 0.000 claims abstract 6
- 108090000623 proteins and genes Proteins 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims 10
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims 3
- 238000003306 harvesting Methods 0.000 claims 2
- 241000272814 Anser sp. Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 210000001776 amniocyte Anatomy 0.000 claims 1
- 230000000890 antigenic effect Effects 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 230000000415 inactivating effect Effects 0.000 claims 1
- 230000002779 inactivation Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 210000003292 kidney cell Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108010067390 Viral Proteins Proteins 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NLPCT/NL02/00718 | 2002-11-08 | ||
| NLPCT/NL02/00718 | 2002-11-08 | ||
| EPPCT/EP03/50129 | 2003-04-28 | ||
| EPPCT/EP03/50129 | 2003-04-28 | ||
| PCT/EP2003/050806 WO2004042042A1 (fr) | 2002-11-08 | 2003-11-07 | Vaccins contre le virus du nil occidental |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2501220A1 true CA2501220A1 (fr) | 2004-05-21 |
| CA2501220C CA2501220C (fr) | 2012-01-17 |
Family
ID=32313778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2501220A Expired - Fee Related CA2501220C (fr) | 2002-11-08 | 2003-11-07 | Vaccins contre le virus du nil occidental |
Country Status (7)
| Country | Link |
|---|---|
| AT (1) | ATE453708T1 (fr) |
| AU (1) | AU2003298277B2 (fr) |
| CA (1) | CA2501220C (fr) |
| DE (1) | DE60330795D1 (fr) |
| IL (1) | IL168374A (fr) |
| NZ (1) | NZ538808A (fr) |
| WO (1) | WO2004042042A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2977470B1 (fr) | 2002-10-16 | 2018-01-03 | Gen-Probe Incorporated | Compositions et procédé pour la détection du virus du nil occidental |
| US7927840B2 (en) | 2006-09-11 | 2011-04-19 | Gen Probe Incorporated | Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region |
| US8052974B2 (en) | 2005-05-12 | 2011-11-08 | Crucell Holland B.V. | Host cell specific binding molecules capable of neutralizing viruses and uses thereof |
| WO2006122964A1 (fr) * | 2005-05-19 | 2006-11-23 | Crucell Holland B.V. | Methodes de production d'un vaccin contre le virus du nil occidental entier inactive |
| EP1724338A1 (fr) * | 2005-05-19 | 2006-11-22 | Crucell Holland B.V. | Méthode de production d'un vaccin de virus de West Nile inactivé complet |
| EP1896069B1 (fr) * | 2005-06-24 | 2013-03-13 | Intervet International BV | Vaccins chimères inactivés et leurs procédés d'utilisation |
| DK1907536T3 (da) | 2005-07-22 | 2010-07-19 | Crucell Holland Bv | Cellelinie til produktion af coronavira |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1103610A1 (fr) * | 1999-11-26 | 2001-05-30 | Introgene B.V. | Production de vaccins de lignées de cellules mammifère immortalisées |
| CA2440593A1 (fr) * | 2001-03-12 | 2002-09-19 | Yale University | Procedes et compositions comprenant des polypeptides du virus west nile |
-
2003
- 2003-11-07 NZ NZ538808A patent/NZ538808A/en not_active IP Right Cessation
- 2003-11-07 AT AT03796004T patent/ATE453708T1/de active
- 2003-11-07 DE DE60330795T patent/DE60330795D1/de not_active Expired - Lifetime
- 2003-11-07 CA CA2501220A patent/CA2501220C/fr not_active Expired - Fee Related
- 2003-11-07 AU AU2003298277A patent/AU2003298277B2/en not_active Ceased
- 2003-11-07 WO PCT/EP2003/050806 patent/WO2004042042A1/fr not_active Application Discontinuation
-
2005
- 2005-05-03 IL IL168374A patent/IL168374A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2501220C (fr) | 2012-01-17 |
| ATE453708T1 (de) | 2010-01-15 |
| NZ538808A (en) | 2008-03-28 |
| AU2003298277B2 (en) | 2009-01-22 |
| IL168374A (en) | 2010-11-30 |
| DE60330795D1 (de) | 2010-02-11 |
| WO2004042042A1 (fr) | 2004-05-21 |
| AU2003298277A1 (en) | 2004-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2410948C (fr) | Procede de purification de particules de replicon des alphavirus | |
| Duarte et al. | Many-trillionfold amplification of single RNA virus particles fails to overcome the Muller's ratchet effect | |
| CA2477954A1 (fr) | Moyens et procede de production de vecteurs d'adenovirus | |
| WO2003088994A3 (fr) | Virus de la vaccine ankara modifiee pour la vaccination des nouveau-nes | |
| NO20051175L (no) | Fremgangsmate til fremstilling av primaere celler og til amplifikasjon av vira under serumfrie betingelser | |
| CA2205015A1 (fr) | Procede de production d'agents biologiques dans un milieu de culture sans proteines | |
| CA2154023A1 (fr) | Virus recombinant infectieux a arn a brin negatif non segmente | |
| YU37502A (sh) | Infektivni klonovi | |
| JP2011078424A (ja) | ウイルス増殖法 | |
| US8852577B2 (en) | Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom | |
| WO1997005255A3 (fr) | Virus auxiliaires pour la preparation de vecteurs viraux recombinants | |
| GB2209764A (en) | Recombinant vaccinia virus | |
| US11534417B2 (en) | Enhanced expression of RNA vectors | |
| CA2501220A1 (fr) | Vaccins contre le virus du nil occidental | |
| Netter et al. | Nucleotide sequence stability of the genome of hepatitis delta virus | |
| WO2020034584A1 (fr) | Population de cellules bhk21 dont le système immunitaire inné est remodelé, et son application dans l'amélioration de la prolifération virale dans les clones cellulaires | |
| JP2006526393A5 (fr) | ||
| AU2002212555A1 (en) | Yeast derived vaccine against ipnv | |
| NO20073809L (no) | Viruspreparater og fremgangsmater | |
| EP2647645B1 (fr) | Protéines recombinées de Parapoxvirus ovis et compositions pharmaceutiques produites à partir de celles-ci | |
| JP6708636B2 (ja) | Ｂｓｔ２遺伝子の機能が喪失された細胞株を利用したウィルス感染促進及び産生増進方法 | |
| NO20005482D0 (no) | Rekombinant virus som uttrykker fremmed DNA som koder for Felin CD80, Felin CTLA-4 eller Felin CD86 og anvendelse derav | |
| WO2000049166A3 (fr) | Systeme de production de vecteurs d'adenovirus dependant d'auxiliaires base sur l'utilisation d'endonucleases | |
| Avery | Abortive infection of L cells by influenza virus: absence of virion RNA synthesis | |
| ES2125842A1 (es) | Clones y vectores infectivos de plantas derivados del virus del mosaico del nabo (tumv). |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20131107 |